Safety requirements are still in place and students are expected to follow the guidelines, according to Wilson.
UGA spokesman Greg Trevor said Monday that the gathering of students was not a registered event on campus, but that the Student Affairs office is investigating.
People on Twitter argued the risks posed by the students engaged in play on the fields.
“These are the people ruining it for the rest of us,” wrote one woman, who identified herself as student. “You have an opportunity to hold these groups accountable and I hope you send a message to those who continue to put other people at risk.”
COVID-19 cases in Athens-Clarke County have been on an upward slope since Dec. 28, 2020, according to the Georgia Department of Public Health. The county saw a 55% increase in cases reported between the last week of December and cases reported last week.
There was a slight dip in daily cases reported in the days following the end of the University of Georgiaâs final exams.
Facing the risks
On Jan. 8, as many students prepared to return to campus for in-person learning, the Centers for Disease Control and Prevention published a study about the risks of in-person learning at large universities for students and the community.
How to prevent reinfection of COVID-19 redandblack.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from redandblack.com Daily Mail and Mail on Sunday newspapers.
After months of restrictions to slow the spread of COVID-19, new vaccines may soon offer a return to normalcy. After encouraging trial data, Pfizer and Moderna have both applied for emergency use authorization from the Food and Drug Administration for their respective vaccines, and the Pfizer-BioNTech vaccine was granted emergency authorization Friday night. Now, the focus shifts to distribution.
The FDA grants emergency use authorization to allow an unapproved medical product to be used in a public health emergency when there are no approved and available alternatives.
The vaccine will cause some distribution challenges. For example, the Pfizer vaccine must be stored at minus 70 degrees Celsius, and both vaccines must be given in two separate doses. One dose of the Pfizer vaccine is about 52% effective, whereas two doses are 95% effective. There is also no evidence that the protection from one dose lasts more than a few weeks without the second dosage.